Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
Acellular, advance, Albino, announced, AOC, Carrier, dose, encouraging, experimental, fifteen, half, hundred, Hyderabad, Indian, joint, local, mice, NDPD, negotiated, Pharma, platform, proceed, Pvt, recovery, refinancing, repeated, running, step, successfully, Telangana, thousand, toxicity, venture, Wistar, Zealand
Removed:
account, active, adhesion, antagonist, aware, bind, body, broad, called, candidate, carbohydrate, cellular, Competitively, controlled, CRD, depleted, derived, divided, domain, downregulated, earlier, entitled, equally, extended, factor, family, feasibility, finalized, found, fourteen, galactomannan, galactoside, galectin, Glucose, hand, Hydrolyze, immune, indispensable, inflammation, Inhibit, interact, interaction, International, investment, Journal, label, lead, lectin, located, Molecular, monthly, movement, multiplication, offering, open, paying, pilot, polysaccharide, projected, published, pursuing, randomised, range, recognition, repay, response, retired, returned, Science, subfamily, surface, survival, type, upregulated, Vaccination, viral
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view